Physician profile
Douglas Estey
NPI 1366405185
$1,402.48
in general payments reported to CMS, 2019-2025
14 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $393 · 2023: $298 · 2024: $133 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $822.25 | 2021-2025 | Tymlos |
| Pharmacosmos Therapeutics INC. | $111.41 | 2025 | Monoferric |
| Amgen INC. | $88.53 | 2021-2025 | Evenity, Prolia, Prolia |
| Kowa Pharmaceuticals America, INC. | $87.38 | 2022-2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $74.83 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $48.92 | 2022-2023 | Zilretta, Iovera, Exparel |
| Djo, LLC | $37.43 | 2024-2025 | Cmf |
| Sandoz INC. | $30.03 | 2025 | Jubbonti |
| Boston Scientific Corporation | $22.83 | 2025 | Wavewriter Alpha Prime 16 |
| Fidia Pharma USA INC. | $19.36 | 2022 | |
| Convatec INC. | $19.29 | 2023 | |
| Pacira Therapeutics, INC. | $15.11 | 2021 | |
| Endo Pharmaceuticals INC. | $13.76 | 2021 | |
| Horizon Therapeutics Plc | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Estey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.